IDENTIFICATION OF ONCOFUSION-INTERACTING PROTEINS AS ESSENTIAL DRUG TARGETS FOR COMMON AND RARE ONCOFUSIONS IN RHABDOMYOSARCOMA

Duke University, Durham NC

Investigators